AstraZeneca Pharma India Limited(IN:ASTRAZEN)
₹6,166.20+133.45 (+2.21%)
IN:ASTRAZEN
AstraZeneca Pharma India Limited earnings date
₹6,166.20
At close:+133.45 (+2.21%)
Want to see IN:ASTRAZEN full AI Analyst Report?
AstraZeneca Pharma India Limited (ASTRAZEN) Q2 2022 Earnings Report
44 Followers
IN:ASTRAZEN Q2 2022 EPS Results
- Actual EPS
- INR 4.78
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- INR 10.54
IN:ASTRAZEN Q2 2022 Revenue Results
- Actual Revenue
- INR 1.98B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 11/09/2021
- Time
- Before Open
- Conference Call
- Tuesday, November 9, 2021
IN:ASTRAZEN Upcoming Earnings
AstraZeneca Pharma India Limited's next earnings date is estimated for February 14, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IN:ASTRAZEN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 14, 2027 | 2027 (Q3) | ―- | 13.04 | ― | ― |
| Nov 05, 2026 | 2027 (Q2) | ―24.93 | 21.69 | 14.96% (+3.24) | |
| Aug 10, 2026 | 2027 (Q1) | ―15.17 | 22.33 | -32.06% (-7.16) | |
| May 26, 2026 | 2026 (Q4) | ―17.95 | 23.3 | -22.95% (-5.35) | |
| Feb 11, 2026 | 2026 (Q3) | ―13.04 | 12.34 | 5.64% (+0.70) | |
| Nov 07, 2025 | 2026 (Q2) | ―21.69 | 15.37 | 41.09% (+6.32) | |
| Aug 14, 2025 | 2026 (Q1) | ―22.33 | -4.72 | 573.54% (+27.05) | |
| May 30, 2025 | 2025 (Q4) | ―23.30 | 15.79 | 47.55% (+7.51) | |
| Feb 11, 2025 | 2025 (Q3) | ―12.34 | 6.32 | 95.25% (+6.02) | |
| Nov 13, 2024 | 2025 (Q2) | ―15.37 | 20.95 | -26.62% (-5.58) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

